1522169535561928709

Today we are sharing preclinical data at the @ISCTglobal Annual Meeting, being held in San Francisco, CA, May 4-7, 2022, on GDA-301 and GDA-601, two NAM-enabled genetically modified natural killer (NK) cell product candidates in our pipeline. More here: https://t.co/cAJbLdxeFT https://t.co/eB2nnTeoDo

Send us a message